Matthew Holt talks one-on-one with Bryan Roberts, who invested in athenahealth, co-founded Castlight, and generally was about 5 years ahead of everyone else investing in digital health.
Matthew Holt chats with a Silicon Valley VC, Rebecca Lynn of Canvas, and Jeff Tangney, CEO of Doximity. Canvas was the lead investor in Doximity’s Series B. This conversation gives an intimate detailed look at the investment criteria both sides face, the evolution of the business model, and how the two work together.
Health 2.0 is just getting into the mainstream. Other tools and approaches like disease management and patient safety seem to have been held back because they can’t prove the elusive ROI. Others, like EMRs & ACOs and almost any med tech intervention and drug you can think of seem to roll right ahead. Thus, how should we think about the business future and likely impact of the technologies we show on stage? What should we all be saying to the health care system? Patient safety expert and all around witty gadfly Michael Millenson joins Matthew Holt to make some suggestions.
Vivek Murthy, the U.S. Surgeon General, discusses how preventable solutions will help eliminate the health challenges US is facing today. In building the culture of prevention, he highlights the 3 components – nutrition, physical activity, and emotional well being – that will help people create solutions that will impact and change the disparities we see today.
Indu, Matthew, and Pascal closed out our two-day event with final thoughts, impressions and hopes for digital health abroad.
Jakob is the Founder of NeuroNation, where they are on a mission to help people keep their brains sharp and have fun at same time.
Dr. Markus Mueschenich is the Co-Founder and Managing Partner of FLYING HEALTH which is a 1:1 accelerator for digital health startups. FLYING HEALTH´s first accelerated investment was Caterna Vision. Caterna Vision provides a digital training developed by scientists. In Health 2.0 Europe, he demoed how Caterna Vision’s digital therapy will help children suffering from amblyopia eg “lazy eye” much faster than using standard therapy.
Being reimbursed for services is the end goal for many digital health companies on the market today. Sat down with the big players in EU finance and explored two CEO’s success stories and saw what it took to end up where they are today.
In this session we examined the barriers to digital health adoption in the EU and what strategies health care organizations and startups can utilize to support a more connected, informed, and intuitive health care system.